Impact of Active Antihyperglycemic Components as Herbal Therapy for Preventive Health Care Management of Diabetes

Current Molecular Medicine
Harsha KashyapRenu Bist

Abstract

Diabetes is a metabolic hyperglycemic condition that progressively develops, effect small and large sensory fibers in the affected population. It has various complications as hypertension, coronary artery disease, stroke, blindness, kidney disease as well as peripheral neuropathy. Sulfonylureas, thiazolidinediones, metformin, biguanidine, acarbose and insulin are commonly used drugs for diabetic patients, but these all have certain side effects. Even metformin, that is known as the miracle drug for diabetes has been found to be associated with side effects, as during treatment it involves complications with eyes, kidneys, peripheral nerves, heart and vasculature. In the present article, we hypothesize recent discoveries with respect to active ingredients from Indian medicinal plants i.e., polypeptide-p (protein analogue act as artificial insulin), charantin (a steroidal saponin), momordicin (an alkaloid) and osmotin (ubiquitous plant protein and animal analogue of human adeponectin) possessing anti-hyperglycemic potential for diabetes type II. Therefore, plants as herbal therapy have preventive care of hyperglycemia accompanied with healthy lifestyle which can provide significant decline in the incidences of diabetes in future.

References

Sep 1, 1989·Diabetes Care·C J Bailey, C Day
Jan 1, 1988·Journal of Ethnopharmacology·M A Ajabnoor, A K Tilmisany
Aug 1, 1985·Southern Medical Journal·M M Korczowski
Dec 1, 1970·The American Journal of Cardiology·L A Kuhn
Nov 1, 1981·Journal of Natural Products·P KhannaV P Dixit
Jun 3, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·J LuoG M Reaven
Oct 9, 1999·Clinical Microbiology Reviews·M M Cowan
Oct 20, 2001·Current Opinion in Plant Biology·F F Assaad
Jun 5, 2002·The Plant Cell·Clarence A RyanDaniel S Moura
Oct 26, 2002·Trends in Plant Science·Claudia Jonak, Heribert Hirt
Feb 1, 2003·Trends in Cell Biology·Sean Oldham, Ernst Hafen
Jul 9, 2004·Medical Hypotheses·Mark F McCarty
Sep 3, 2004·Drug Discovery Today·Yoshimichi Sai, Akira Tsuji
Jul 11, 2006·The Journal of Clinical Investigation·Takashi KadowakiKazuyuki Tobe
Jan 19, 2008·Journal of Nutritional Science and Vitaminology·Takashi UebansoEiji Takeda
Jul 31, 2010·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Graham ThornicroftDawit Wondimagegn
Jun 7, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Purusotam Basnet, Natasa Skalko-Basnet
Oct 4, 2011·The Open Medicinal Chemistry Journal·Jaipaul SinghErnest Adeghate
Feb 23, 2012·British Journal of Pharmacology·Aileen J F King
Sep 7, 2012·Cold Spring Harbor Perspectives in Biology·Brian A Hemmings, David F Restuccia
Aug 1, 2000·Indian Journal of Clinical Biochemistry : IJCB·R ShukiaP S Murthy
Mar 1, 1996·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·A Raman, C Lau
Mar 1, 1997·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·E Ernst
Oct 1, 1995·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·R J Marles, N R Farnsworth
Nov 5, 2014·Current Diabetes Reports·Sonal Singh
Aug 19, 2015·Biotechnology Advances·Atanas G AtanasovHermann Stuppner
Oct 6, 2015·Journal of Diabetes and Metabolic Disorders·Arpana GaddamPaturi V Rao
Jun 28, 2016·Experimental and Therapeutic Medicine·Sae Kwang KuJoo Wan Kim
Mar 3, 2018·Diabetes Research and Clinical Practice·N H ChoB Malanda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.